Eikonizo Therapeutics, Inc.

Cambridge, MA

UEI
VR8XJTTBS2M7
CAGE
7ZGT1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
245 Main St Fl 2, Cambridge, MA 02142, USA
Website
eikonizo.com
Founded
2017
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Eikonizo Therapeutics, Inc.'s 3 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Next-generation CNS-penetrant HDAC6 inhibitors: proof-of-principle in parkinson's disease - summary: parkinson's disease… Grant · R43NS141467 National Institute of Neurological Disorders and Stroke $499,766
Mechanistic validation of selective brain-penetrant HDAC6 inhibitors as a disease- modifying treatment for tauopathies… Grant · R43AG067939 National Institute on Aging $509,669
Targeting HDAC6 to modulate titin stiffness for dilated cardiomyopathy therapy Grant · R43HL154959 National Heart Lung and Blood Institute $299,983

Quick answers

What is Eikonizo Therapeutics, Inc.'s UEI?

Eikonizo Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is VR8XJTTBS2M7.

What is Eikonizo Therapeutics, Inc.'s CAGE code?

Eikonizo Therapeutics, Inc.'s CAGE code is 7ZGT1.

What is Eikonizo Therapeutics, Inc.'s primary NAICS code?

Eikonizo Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Eikonizo Therapeutics, Inc. located?

Eikonizo Therapeutics, Inc.'s physical address in SAM.gov is 245 Main St Fl 2, Cambridge, MA 02142, USA.

Is Eikonizo Therapeutics, Inc. registered in SAM.gov?

Yes. Eikonizo Therapeutics, Inc.'s SAM.gov registration is active through December 11, 2026.

What is Eikonizo Therapeutics, Inc.'s most recent federal award?

Eikonizo Therapeutics, Inc.'s most recent federal grant award is Next-generation CNS-penetrant HDAC6 inhibitors: proof-of-principle in parkinson's disease - summary: parkinson's disease… (R43NS141467), from National Institute of Neurological Disorders and Stroke, on August 1, 2025.

On GovTribe

See Eikonizo Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login